miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis
Publication in refereed journal


Times Cited
Web of Science27WOS source URL (as at 16/09/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractBackground: As a distinctive type of head and neck cancers, nasopharyngeal carcinoma (NPC) is genesis from the clonal Epstein-Barr virus (EBV)-infected nasopharyngeal epithelial cells accumulated with multiple genetic lesions. Among the recurrent genetic alterations defined, loss of 9p21.3 is the most frequent early event in the tumorigenesis of EBV-associated NPC. In addition to the reported CDKN2A/p16, herein, we elucidated the role of a miRNA, miR-31 within this 9p21.3 region as NPC-associated tumor suppressor.
All Author(s) ListCheung CCM, Chung GTY, Lun SWM, To KF, Choy KW, Lau KM, Siu SPK, Guan XY, Ngan RKC, Yip TTC, Busson P, Tsao SW, Lo KW
Journal nameMolecular Cancer
Detailed descriptiondoi: 10.1186/1476-4598-13-184.
Year2014
Month8
Day7
Volume Number13
PublisherBIOMED CENTRAL LTD
ISSN1476-4598
LanguagesEnglish-United Kingdom
KeywordsFIH1; MCM2; MicroRNA; miR-31; Nasopharyngeal carcinoma
Web of Science Subject CategoriesBiochemistry & Molecular Biology; BIOCHEMISTRY & MOLECULAR BIOLOGY; Oncology; ONCOLOGY

Last updated on 2020-17-09 at 02:04